Hanafusa T, Pujol-Borrell R, Chiovato L, Russell R C, Doniach D, Bottazzo G F
Lancet. 1983 Nov 12;2(8359):1111-5. doi: 10.1016/s0140-6736(83)90628-1.
To investigate the expression of class II histocompatibility antigens HLA-DR in the thyrocytes in autoimmune thyroid diseases, 47 thyroidectomy specimens were examined by immunofluorescence with monoclonal antibodies to the nonpolymorphic region of the DR molecule. Aberrant DR expression was most marked in the Hashimoto gland, with the entire section being strongly stained. DR expression was seen in discrete groups of follicles in 20/26 thyroids from patients with Graves' disease, in 2/9 non-toxic nodular goitres, and in none of 11 specimens of "normal" thyroid. The presence of lymphoid foci, "activated" T-cells, and immune complexes on the follicular basement membrane were not regularly associated with the DR-positive thyroid acini. HLA-A,B,C expression was also increased in the diseased glands. Expression of HLA-DR thus seems to be one of the earliest manifestations of autoimmune lymphocytic thyroiditis.
为研究自身免疫性甲状腺疾病中甲状腺细胞上II类组织相容性抗原HLA - DR的表达情况,采用针对DR分子非多态性区域的单克隆抗体,通过免疫荧光法检测了47份甲状腺切除标本。DR异常表达在桥本甲状腺中最为显著,整个切片均被强烈染色。在26例Graves病患者的20例甲状腺中,可见散在的滤泡组有DR表达;在9例非毒性结节性甲状腺肿中有2例有DR表达;而在11份“正常”甲状腺标本中均未发现DR表达。滤泡基底膜上存在淋巴样灶、“活化”T细胞和免疫复合物,这些与DR阳性的甲状腺腺泡并无规律的相关性。患病腺体中HLA - A、B、C的表达也有所增加。因此,HLA - DR的表达似乎是自身免疫性淋巴细胞性甲状腺炎最早的表现之一。